General Information of the Compound
| Compound ID |
CP0480150
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-2-[1,3-diethyl-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-N-methyl-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H33F3N4O
|
||||||||||||||||||
| Molecular Weight |
498.593
|
||||||||||||||||||
| Canonical SMILES |
CCc1nc(CC)n2CCN([C@@H](C(=O)NC)c3ccccc3)C(CCc3ccc(cc3)C(F)(F)F)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H33F3N4O/c1-4-22-26-23(16-13-19-11-14-21(15-12-19)28(29,30)31)34(17-18-35(26)24(5-2)33-22)25(27(36)32-3)20-9-7-6-8-10-20/h6-12,14-15,23,25H,4-5,13,16-18H2,1-3H3,(H,32,36)/t23?,25-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GAWATXZDBWIYHK-XSWBTSGESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1